drugset / Trial / NCT06713733

Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery

NCT06713733

RandomizedParallel-groupSingle-blindTreatment

Summary

Pain, edema and trismus are the most frequent postoperative sequelae to surgical removal of impacted teeth, all of are due to the local inflammatory response. Use of corticosteroids decrease tissue mediators of inflammation and reduce edema. Use of trypsin-chymotrypsin elaborates the enzymes esterase in blood plasma that inhibits inflammation by hydrolytic degradation of the inflammatory peptides.

Timeline

Start
2024-09-25
Primary completion
2024-12-25
Completion
2025-01-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chymotrypsin Protein / enzyme biologic 1 unknown Oral
Comparator Dexamethasone Small molecule 8 mg Other

Indications

No indication recorded.